We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6465:TSEHOSHIZAKI Corp. Analysis

Data as of 2026-09-11 - not real-time

¥5,305.00

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Hoshizaki Corporation is neutral at ¥5,305.00, with no clear ordering between short and long averages. It has lost 8.8% over the past 30 days. RSI sits at 32.4, which reads as approaching oversold, and MACD momentum is bearish. The recent range runs from support at ¥5,216.00 up to resistance at ¥5,818.00.
The shares look undervalued, trading on 19.4 times earnings below a sector average of 27.7. Analyst price targets sit 25.7% above the current price. Revenue is growing at 14.7% on a 7.4% profit margin. The 2.18% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 17.6%, a beta of 0.04 and a maximum drawdown of 17.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.

Top Market Events

Detailed price information for Hoshizaki Electric CO Ord HSHIF from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 5298.16
  • MACD momentum is negative
  • 30-day price change of -8.8%

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 19.4 versus sector average of 27.7
  • Trading above the 200-day average of 5298.16
  • Analyst targets imply +25.7% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 19.4 versus sector average of 27.7
  • Analyst targets imply +25.7% versus the current price
  • Revenue growth of +14.7%

Key Metrics & Analysis

Financial Health

Revenue Growth14.70%
Profit Margin7.39%
P/E Ratio19.4
ROE9.84%
ROA5.93%
Debt/Equity1.60
P/B Ratio1.8
Op. Cash Flow¥46.1B
Free Cash Flow¥27.8B
Industry P/E27.7

Technical Analysis

TrendNeutral
RSI32.4
Support¥5,216.00
Resistance¥5,818.00
MA 20¥5,585.40
MA 50¥5,591.98
MA 200¥5,298.17
MACDBearish
VolumeIncreasing
Fear & Greed Index90.8

Valuation

Fair Value¥5,757.71
Target Price¥6,666.25
Upside/Downside25.66%
GradeUndervalued
TypeBlend
Dividend Yield2.18%

Risk Assessment

Beta0.04
Volatility17.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.